assessment of the abuse liability of three menthol Vuse Solo electronic cigarettes relative to combustible cigarettes and nicotine gum
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Stiles (2018)
Regulating food craving: From mechanisms to interventions.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Sun (2020)
Youth use of e-cigarettes: Does dependence vary by device type?
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Tackett (2021)
The role of E-liquid vegetable glycerin and exhaled aerosol on cue reactivity to tank-based electronic nicotine delivery systems (ENDS).
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Vena (2019)
Exposure to JUUL use: cue reactivity effects in young adult current and former smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Vena (2020)
an Examination of Differences in acute Nicotine Withdrawal Symptoms between Electronic Nicotine Delivery System and Combustible Cigarette Use.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Versella (2022)
On the toxicity of e-cigarettes consumption: Focus on pathological cellular mechanisms.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Vivarelli (2022)
Prevalence of and disparities in adolescents' susceptibility to novel oral nicotine products marketed as "tobacco-free".
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Vogel (2023)
What is the nicotine delivery profile of electronic cigarettes?
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Voos (2019)
E-Cigarette aerosol Deposition and Disposition of [11C]Nicotine Using Positron Emission Tomography: a Comparison of Nicotine Uptake in Lungs and Brain Using Two Different Nicotine Formulations.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Wall (2022)